
|Slideshows|February 22, 2018
Adjunctive Cannabidiol Therapy in Schizophrenia
Author(s)Brian Miller, MD, PhD, MPH
New research looks at the effects of CBD on positive and negative psychotic symptoms, cognitive performance, level of functioning, and the treating psychiatrist’s overall clinical impression.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Top 10 Misleading Claims About Antidepressants
2
New Positive Data From Largest Real-World Study of Deep TMS in Patients With Comorbid PTSD and MDD
3
Tribalism in Psychiatry: On the Mind of John J. Miller, MD
4
Podcast: Deprescribing Insights From an ASCP Panel of Psychiatric Experts
5











